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This rigorous thesis describes current approach to therapy of type 1 and type 2 
diabetes mellitus in adult patients. The theoretical part includes subchapters related 
to evaluation of diabetes mellitus compensation, non-pharmacological measures 
and especially pharmacological treatment of this disease. Additionally it sums up key 
information about drugs available on the Czech market (metformin, pioglitazone, 
sulfonylurea derivatives, repaglinide, acarbose, dipeptidyl peptidase 4 inhibitors, 
glucagon-like peptide 1 analogs, gliflozines, insulins and insulin analogs) 
and recommended therapy. Furthermore separate subchapter is dedicated to continuous 
subcutaneous insulin infusion with an insulin pump. The experimental part introduces 
therapy of the disease on sample of 100 patients (50 type 1 diabetic patients 
and 50 type 2 diabetic patients) in a selected diabetes clinic. In addition 
to the pharmacological treatment and its results, selected patient data (for example age 
at which a diagnosis was made, duration of the illness, some comorbidities etc.) are also 
mentioned. Patient’s medical records were the source of information. Data collection 
took place from October 2016 to May 2017. The second subchapter of the experimental 
part of the thesis includes the output from questionnaires, which were filled in 
by diabetics visiting the above-mentioned clinic. The results from both subchapters 
of the experimental part were processed into graphs and tables. Considering 
the individual approach to patients, the therapeutics ways and their effects were also 
illustrated on some casuistries. The next section of the thesis discusses current strategy 
of the pharmacotherapy of diabetes, certain benefits deriving from defined treatment 
as well as economic influence. The conclusion sums up the practical importance of each 
drug/ drug class.  It emphasises once more the necessity of individual approach 
and importance of compliance with non-pharmacological measures. 
